Pancreatic Cancer Research

ResearcherUniversitair Ziekenhuis LeuvenActive in the last 2 years

Halit Topal

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5869-6296; OpenAlex author ID A5083693824. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Real-world feasibility and safety of neoadjuvant FOLFIRINOX in pancreatic ductal adenocarcinoma: a retrospective single-center study. Co-author DOI 10.21037/jgo-2026-1-0041↗
  2. Progression-free survival for unresectable non-metastatic locally advanced pancreatic cancer after surgical microwave ablation plus durvalumab and tremelimumab… Co-author DOI 10.1038/s43856-025-01186-x↗
  3. Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer. First author DOI 10.1038/s41467-024-52978-z↗
  4. Survival After Minimally Invasive vs Open Surgery for Pancreatic Adenocarcinoma. Co-author DOI 10.1001/jamanetworkopen.2022.48147↗
  5. 3D-laparoscopic pancreaticoduodenectomy with superior mesenteric or portal vein resection for pancreatic cancer. First author DOI 10.1007/s00464-020-07847-3↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Baki Topal · 5 shared papers, 2020–2026 · strength 1.13
  2. Soetkin D’Haens · 1 shared paper, 2026 · strength 0.36
  3. Jeroen Dekervel · 1 shared paper, 2026 · strength 0.36
  4. Joachim Geers · 2 shared papers, 2020–2022 · strength 0.34
  5. Eric Van Cutsem · 1 shared paper, 2025 · strength 0.27
  6. Johannes V. Swinnen · 1 shared paper, 2024 · strength 0.17
  7. Vincent de Laat · 1 shared paper, 2024 · strength 0.17
  8. Maria Fedorova · 1 shared paper, 2024 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.